InvestSMART

Imagion Biosystems Limited (ASX: IBX) - Announcements

- Current share price for IBX : $0.005

ASX company news and announcements for Imagion Biosystems Limited (IBX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imagion Biosystems Limited (IBX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imagion Biosystems Limited (IBX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imagion Biosystems Limited (IBX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 FY25 Appendix 4E and Annual Report 27 Feb 2026 2:55PM $0.028 $0.005 fallen by 81.82%
$4 IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial 2 Feb 2026 9:17AM $0.024 $0.005 fallen by 79.17%
$4 Appendix 4C and Quarterly Activities Report - December 2025 29 Jan 2026 9:50AM $0.025 $0.005 fallen by 80%
$4 Cleansing Notice 9 Jan 2026 9:41AM $0.030 $0.005 fallen by 83.33%
$4 Application for quotation of securities - IBX 9 Jan 2026 9:33AM $0.030 $0.005 fallen by 83.33%
$4 Mercer Convertible Securities Conversion and Amendment 8 Jan 2026 10:07AM $0.033 $0.005 fallen by 84.85%
$4 Change of Director's Interest Notice - Robert Proulx 6 Jan 2026 3:13PM $0.029 $0.005 fallen by 82.76%
$4 Cleansing Notice 6 Jan 2026 3:10PM $0.029 $0.005 fallen by 82.76%
$4 Application for quotation of securities - IBX 6 Jan 2026 3:06PM $0.029 $0.005 fallen by 82.76%
$4 Updated Securities Trading Policy 18 Dec 2025 2:03PM $0.021 $0.005 fallen by 76.19%
$4 Cleansing Notice 15 Dec 2025 9:53AM $0.021 $0.005 fallen by 76.19%
$4 Application for quotation of securities - IBX 15 Dec 2025 9:52AM $0.021 $0.005 fallen by 76.19%
$4 Notification of cessation of securities - IBX 10 Dec 2025 3:40PM $0.020 $0.005 fallen by 75%
$4 Cleansing Notice 4 Dec 2025 2:28PM $0.021 $0.005 fallen by 76.19%
$4 Application for quotation of securities - IBX 4 Dec 2025 2:27PM $0.021 $0.005 fallen by 76.19%
$4 Positive Final WSU Trial Results To Support IND Submission 1 Dec 2025 3:31PM $0.022 $0.005 fallen by 77.27%
$4 Positive Results Received from WSU on MagSense Dosage 5 Nov 2025 9:32AM $0.023 $0.005 fallen by 78.26%
$4 Appendix 4C and Quarterly Activities Report - September 2025 21 Oct 2025 9:42AM $0.031 $0.005 fallen by 83.87%
$4 Application for quotation of securities - IBX 16 Oct 2025 9:49AM $0.034 $0.005 fallen by 85.29%
$4 Cleansing Notice 16 Oct 2025 9:49AM $0.034 $0.005 fallen by 85.29%
$4 Application for quotation of securities - IBX 10 Oct 2025 10:06AM $0.038 $0.005 fallen by 86.84%
$4 Cleansing Notice 10 Oct 2025 10:06AM $0.038 $0.005 fallen by 86.84%
$4 Imagion Biosystems HER2 Breast Cancer Program Update 7 Oct 2025 9:46AM $0.034 $0.005 fallen by 85.29%
$4 Application for quotation of securities - IBX 1 Oct 2025 9:17AM $0.036 $0.005 fallen by 86.11%
$4 Cleansing Notice 1 Oct 2025 9:16AM $0.036 $0.005 fallen by 86.11%

51 - 75 of 693 results

Page 3 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.